Macroaxis: Personalized Investing  
Macroaxis Country Selector USA  Change      Macroaxis User Registration Register    Macroaxis User Login Sign In
   
 US Market Closed: Feb 9, 08:00 AM 2012 
  NYSE  8082.98    NASDAQ  2915.86  
 and more..
Search
sponsered by
  
  



Processing. Please wait...
       

SEC Filing Search

       
  Companies   Sectors   Advisers
       
    
       
       
 
Sponsored by
     
Search for key public statements, documents, or other formal exhibits submitted to the U.S. Securities and Exchange Commission (SEC). Financial professionals and sophisticated investors use these filings to find information on companies they are evaluating for investment purposes.
       
    
Symbol  SLXP
Name  Salix Pharmaceuticals Ltd.
TypeStock
Country  Macroaxis: United States United States
Exchange  NASDAQ
    
Stock @ NASDAQ  Financials, Profile and Fundamentals for SLXP Summary Financials, Profile and Fundamentals for SLXP Profile Risk and Volatility for SLXP Volatility  History SLXP PR and Media News Discussion for SLXP Chats
    
    
    

Current Reports

 
Current report
 Filed: 2012-01-05 AccNo: 0001193125-12-003536 Size: 18 KB
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits
 
Current report
 Filed: 2011-12-27 AccNo: 0001193125-11-352927 Size: 58 KB
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits
 
Current report
 Filed: 2011-12-14 AccNo: 0001193125-11-340877 Size: 21 KB
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

CT ORDER

 
Confidential treatment order
 Filed: 2011-12-28 AccNo: 9999999997-11-017805 Size: 14 KB

Quarterly Reports

 
Quarterly report [Sections 13 or 15(d)]
 Filed: 2011-11-09 AccNo: 0001193125-11-303454 Size: 4 MB

SC 13G

 
Statement of acquisition of beneficial ownership by individuals
 Filed: 2011-09-22 AccNo: 0001144204-11-054352 Size: 491 KB
    

Want to optimize your portfolio? Find out here

       
Total Portfolio Builder

Analyze Portfolios

       
  
       

Optimize Positions

       
  
       
Portfolio Monitor

Monitor & Rebalance

       
       
       
  
    
 
Statement of changes in beneficial ownership of securities
 Filed: 2012-02-07 AccNo: 0001209191-12-008183 Size: 11 KB
 
Statement of changes in beneficial ownership of securities
 Filed: 2012-02-07 AccNo: 0001209191-12-008179 Size: 9 KB
 
Statement of changes in beneficial ownership of securities
 Filed: 2012-02-07 AccNo: 0001209191-12-008173 Size: 12 KB
 
Statement of changes in beneficial ownership of securities
 Filed: 2012-02-07 AccNo: 0001209191-12-008167 Size: 5 KB
 
Statement of changes in beneficial ownership of securities
 Filed: 2012-01-26 AccNo: 0001209191-12-005533 Size: 14 KB
 
Statement of changes in beneficial ownership of securities
 Filed: 2012-01-19 AccNo: 0001209191-12-004480 Size: 18 KB
 
Statement of changes in beneficial ownership of securities
 Filed: 2012-01-19 AccNo: 0001209191-12-004475 Size: 15 KB
 
Statement of changes in beneficial ownership of securities
 Filed: 2012-01-05 AccNo: 0001209191-12-002169 Size: 11 KB
 
Statement of changes in beneficial ownership of securities
 Filed: 2012-01-05 AccNo: 0001209191-12-002158 Size: 4 KB
 
Statement of changes in beneficial ownership of securities
 Filed: 2012-01-05 AccNo: 0001209191-12-002152 Size: 4 KB
    

 
Analytics
Investor Landscape
Efficient Frontier
Market Correlation
Risk and Return Analysis
Financial Content New financial content
Portfolio Projections
Retirement Optimizer
RSS and Mobile Access
Market
FAQs
Stock Screener
Fund Screener
ETF Screener
Company Directory
Advisor Directory
Technology
Wealth Management
About Us
About Macroaxis
Contact Us
Terms Of Use
Privacy Policy
Site Map
Product Tour
Investment Services
More ROI More Return on Investment
© 2011 Macroaxis Inc. All rights reserved